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Abstract
Previous studies in Drosophila melanogaster have demonstrated that many tumor suppressor pathways impinge on Rb/E2F
to regulate proliferation and survival. Here, we report that Tuberous Sclerosis Complex 1 (TSC1), a well-established tumor
suppressor that regulates cell size, is an important regulator of dE2F1 during development. In eye imaginal discs, the loss of
tsc1 cooperates with rbf1 mutations to promote ectopic S-phase and cell death. This cooperative effect between tsc1 and
rbf1 mutations can be explained, at least in part, by the observation that TSC1 post-transcriptionally regulates dE2F1
expression. Clonal analysis revealed that the protein level of dE2F1 is increased in tsc1 or tsc2 mutant cells and conversely
decreased in rheb or dTor mutant cells. Interestingly, while s6k mutations have no effect on dE2F1 expression in the wild-
type background, S6k is absolutely required for the increase of dE2F1 expression in tsc2 mutant cells. The canonical TSC/
Rheb/Tor/S6k pathway is also an important determinant of dE2F1-dependent cell death, since rheb or s6k mutations
suppress the developmentally regulated cell death observed in rbf1 mutant eye discs. Our results provide evidence to
suggest that dE2F1 is an important cell cycle regulator that translates the growth-promoting signal downstream of the TSC/
Rheb/Tor/S6k pathway.
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Introduction
Retinoblastoma (Rb) family proteins are important regulators of
cell cycle progression and survival (reviewed in [1,2]). Orthologs of
Rb exist in all metazoans where their functions are evolutionarily
conserved (reviewed in [3]). Their best-known molecular function
is to physically interact with E2F family proteins and transcrip-
tionally repress E2F-regulated target genes. Genome-wide expres-
sion studies revealed that genes involved in various biological
processes, such as cell cycle progression, survival, and develop-
ment, are regulated by E2F family proteins [4–6]. As a
consequence, the loss of Rb family genes in mice results in
developmental defects that are often associated with uncontrolled
S-phase entry and ectopic cell death [7–9]. Importantly, reducing
E2F activity largely suppresses the Rb mutant phenotypes,
indicating that deregulated E2F activity is responsible for the
defects [10,11]. Overall, E2F family proteins are the key molecular
targets of Rb family proteins and responsible for the developmen-
tal consequence of Rb inactivation.
The long-term consequence of Rb inactivation in mammals is
tumorigenesis. In humans, the loss of Rb is believed to be a critical
step for retinoblastoma development. Moreover, Rb is believed to
be functionally inactivated in most, if not all, cancers (reviewed in
[12]). In mice, Rb heterozygosity (Rb+/2) results in the formation
of pituitary and thyroid tumors [7,13–16]. The wild type copy of
the Rb gene is lost in these tumors, illustrating the importance of
Rb as a tumor suppressor gene. Moreover, conditional knockout of
Rb and an additional member of the Rb family gene, p107 or p130,
in mouse retina is sufficient to promote retinoblastoma develop-
ment [17–20]. Similar to the developmental phenotype, deregu-
lated E2F plays a major role during tumorigenesis in Rb mutant
mice. In a pituitary tumor model, the loss of E2f-1 or E2f-3
reduces the frequency of tumor development [21,22]. More
recently, the importance of E2F family proteins in human cancer is
further illustrated by the findings that E2F family proteins
themselves are often deregulated in many types of cancers
(reviewed in [23]). Clearly, E2F family proteins play a critical
role during tumorigenesis and also contribute to the developmen-
tal defects observed in Rb mutant animals.
Although it is clear that studying the function of E2F is crucial
to understand the biology of Rb mutant animals and cancers, it
has been difficult to dissect the in vivo roles of E2F family genes in
mammals. One of the difficulties is the fact that E2F family
proteins can functionally compensate for each other, which is
particularly true for the subset of E2F proteins called ‘‘activator
E2Fs’’ (reviewed in [24]). This is best demonstrated by a recent
study showing that a single ‘‘activator E2F’’, E2F-3a, is sufficient
to support embryonic and post-natal development in mice, and the
expression of E2F-3b or E2F-1 under the control of E2F-3a
promoter can perform the role of E2F-3a [25]. This study suggests
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largely determined by their expression patterns and not by the
differences of their protein sequences. Interestingly, Drosophila
melanogaster has only a single ‘‘activator E2F’’, dE2F1. The function
of dE2F1 is evolutionarily conserved and represents the three
‘‘activator E2Fs’’ in mammals. dE2F1 is required for cellular
proliferation and controls DNA damage-induced cell death,
activities that are shared by the three ‘‘activator E2Fs’’ in
mammals (reviewed in [3]). Since dE2F1 is the sole member
carrying out the function of three E2Fs in mammals, it is possible
that the regulation of dE2F1 expression is more complex and
tightly controlled in flies. However, the regulatory mechanism that
controls dE2F1 expression in Drosophila is poorly understood.
Like Rb, RBF1 is the major regulator of dE2F1 in flies. Most of
the rbf1 mutant phenotypes are believed to be due to deregulated
dE2F1 and can be rescued by a hypomorphic mutant allele of
de2f1 [26]. Because of its simplicity and conserved developmental
function, the Drosophila Rb/E2F is considered as a simplified
version of mammalian Rb/E2F. Although rbf1 mutations are not
sufficient to promote tumor phenotype in Drosophila, recent genetic
studies revealed that RBF1/dE2F1 plays a crucial role when
proliferation and/or survival are compromised by various tumor-
promoting mutations. For example, dE2F1 is required by hippo
mutant cells to overcome the developmentally regulated cell cycle
arrest in eye imaginal discs [27]. Moreover, dE2F1-dependent cell
death limits the growth promoting effect of the archipelago
mutations in the eye, and cooperates with low EGFR activity to
promote cell death [28,29]. Interestingly, although the Drosophila
p53 (dp53) does not genetically interact with rbf1 during
development, dE2F1 and p53 cooperate to promote DNA
damage- induced cell death as they do in mammalian systems
[30]. Overall, RBF1/dE2F1 can either promote and/or limit the
proliferation of cells that carry tumor-promoting mutations in flies.
Tuberous Sclerosis Complex 1 (TSC1) is a tumor suppressor
gene that is mutated in benign tumors (reviewed in [31]). The in
vivo function of TSC1 was first identified in Drosophila melanogaster as
a regulator of cell size and proliferation (reviewed in [32]). TSC1 is
a negative regulator of the Ras Homolog Enriched in Brain
(Rheb), which is an activator of Target of Rapamycin (Tor). The
canonical TSC/Rheb/Tor pathway has been established as a
central network governing cell size and growth regulation.
Although initial reports clearly demonstrated that TSC1 inactiva-
tion perturbs the cell cycle profile, less is understood about the
mechanism by which TSC1 controls the cell cycle as well as cell
size. Here, we demonstrate that tsc1 mutations cooperate with rbf1
mutations to promote both unscheduled S-phase entry and cell
death during Drosophila eye development. This cooperative effect
between tsc1 and rbf1 mutations can be explained, at least in part,
by the observation that dE2F1 expression is post-transcriptionally
increased in tsc1 mutant cells. A dE2F-reporter construct, PCNA-
GFP, is activated in tsc1 mutant cells, and de2f1 mutations
completely suppress the ectopic cell death observed in the rbf1 and
tsc1 double mutant cells, indicating that dE2F1 is activated by tsc1
mutations and required for cooperative effect between rbf1 and tsc1
mutations. We further demonstrate that Rheb and Tor control
dE2F1 expression, and s6k mutations completely abolish the
increase of dE2F1 expression observed in tsc2 mutant cells. These
results demonstrate that the TSC/Rheb/Tor/S6k pathway is an
important regulator of dE2F1 expression during development and
cooperates with RBF1 to regulate cell cycle progression and
survival.
Results
tsc1 and rbf1 mutations cooperate to promote S-phase
entry and cell death
Ectopic S-phase entry and cell death are well-established Rb
loss-of-function phenotypes. To address the question whether
growth-promoting mutations could alter the Rb mutant pheno-
types, we sought to determine the effects of inactivating the
Drosophila ortholog of Tuberous Sclerosis Complex 1 (TSC1) in an
rbf1 mutant background. To test this, tsc1 mutant clones were
generated in wild type or rbf1 mutant eye discs (Figure 1). Since
homozygous rbf1 null flies die at the first instar larval stage, we
used an rbf1 hypomorphic allele, rbf1
120a. Mitotic tsc1 mutant
clones were generated by expressing Flippase (FLP) with an eye-
specific driver and marked by the absence of GFP. Thus, GFP
negative clones in wild type background have only tsc1 mutations
while GFP negative clones in the rbf1
120a background have both
rbf1 and tsc1 mutations. Third instar larval eye discs were dissected
and immunostained with anti-BrdU antibodies. During normal
eye development in Drosophila, S- phase cells, which can be labeled
with BrdU, are found at the anterior portion of the eye imaginal
disc where cells are asynchronously dividing, and immediately
posterior to the Morphogenetic Furrow (MF) where some cells
undergo an extra S-phase called the Second Mitotic Wave
(Figure 1A). At the MF, asynchronously dividing precursor cells
arrest in G1 and begin differentiation process. Therefore,
normally, there is no BrdU incorporating cells at the MF.
Surprisingly, in clones that are double mutant for rbf1 and tsc1,
ectopic S-phase cells were readily observed at the MF (Figure 1C).
Since we can occasionally detect rbf1 mutant cells entering S-phase
at the MF, we compared the number of ectopic BrdU positive cells
at the MF between rbf1 single and rbf1 tsc1 double mutant clones.
We normalized the number of ectopic BrdU positive cells by the
clone size, which is measured by the number of the pixels in
images taken at the same magnification. Clones that do not
contain ectopic BrdU positive cells are excluded from the analysis.
We determined that, on average, 3.762.2 ectopic S-phase cells/
1000 pixels are present in the rbf1 clones while 12.465.6 ectopic S-
phase cells/1000 pixels cells are present in the rbf1 tsc1 double
mutant clones, showing more than 3 fold increase. This result
indicates that RBF1 and TSC1 cooperatively regulate G1 to S-
phase transition. Next, we stained for dying cells with anti-cleaved
Caspase 3 antibodies (C3). rbf1 mutant cells undergo apoptosis at
the anterior region of the MF, and this is not observed in the wild
type eye disc (Figure 1B). We had previously reported that this
developmentally regulated cell death in rbf1 mutant eye discs is
dE2F1-dependent [29]. tsc1 mutant cells also undergo apoptosis
just anterior to the MF though the level of cell death is much lower
than what is observed in rbf1
120a eye discs. However, in clones that
are double mutant for rbf1 and tsc1, we observed a great increase
in C3 staining at the MF and the anterior region of the eye disc
(Figure 1B and 1C). Therefore, we concluded that RBF1 and
Author Summary
Tuberous Sclerosis Complex genes 1 (TSC1) is a down-
stream component of the Insulin Receptor signaling
pathway that is often deregulated in many tumors. In this
study, we discovered that the fruit fly homolog of TSC1
regulates E2F transcription factor by controlling protein
expression. E2F family proteins are key regulators of
cellular division, and other tumor promoting events are
previously shown to regulate E2F activity. Our findings
demonstrate the importance of altering the E2F activity
during tumorigenesis and provide new insights into the
crosstalk between tumor promoting events.
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Drosophila eye development.
TSC1 regulates dE2F1 protein expression
post-transcriptionally
RBF1 is best characterized as a regulator of dE2F1 transcription
factors whose activity promotes both S-phase entry and apoptosis.
Since we observed that tsc1 mutations are able to enhance both
ectopic S-phase entry and cell death phenotypes inrbf1mutant cells,
we sought to determine if dE2F1 itself is deregulated by tsc1
mutations. Eye discs containing tsc1 mutant clones were generated
as described previously and immunostained with an anti-dE2F1
antibody. We observed that the intensity of dE2F1 staining is clearly
stronger in tsc1 homozygous mutant clones throughout the eye disc,
both in dividing and differentiating cells (Figure 2A and Figure
S1A). Moreover we detected similar increase in antenna and wing
Figure 1. tsc1 and rbf1 mutations cooperate to promote S-phase entry and cell death during eye development. tsc1
R453X mutant clones
are generated in wild type and rbf1
120a mutant eye discs by FLP-induced mitotic recombination. Wild type clones are marked with GFP (green) and
the lack of GFP indicates tsc1
R453X mutant clones. Control (w
1118) and rbf1
120a eye discs without tsc1
R453X mutant clones are also presented. The
position of the Morphogenetic Furrow (MF) is indicated by a yellow arrow. (A) Third instar eye discs of indicated genotypes are treated with BrdU, and
S-phase cells are visualized by anti-BrdU antibody (red). (B) To visualize apoptotic cells in the eye discs of the same genotypes, antibodies that
recognize the cleaved form of Caspase 3 (C3) are used (white). (C) Images of higher magnification of the eye discs containing tsc1 mutant clones in
rbf1 mutant background are shown. Note that the cells with both tsc1 and rbf1 mutations ectopically enter S-phase at the MF, and the C3 staining is
stronger in the double mutant clones. (D) Numbers of ectopic BrdU positive cells within the MF are counted and normalized by the sizes of clones.
The clone sizes are determined by counting the numbers of pixels that encompass the region between the first and second mitotic waves. Total of 12
rbf1 single and 20 rbf1 tsc1 double mutant clones are analyzed. The error bars indicate standard deviation.
doi:10.1371/journal.pgen.1001071.g001
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tissue-specific (Figure S1B and S1C). Importantly, the intensity of
dE2F2 staining, the only other member of the E2F family in
Drosophila, is unchanged in tsc1 mutant cells (Figure 2A), indicating
that the effect of tsc1 mutations on dE2F1 expression is specific. To
confirm the immunostaining result, we performed immunoblot
assays using protein extracts from eye imaginal discs comprised
mostly of tsc1 mutant cells (see Materials and Methods). Consistent
withthe immunostainingexperiments,dE2F1proteinlevel is higher
in tsc1 mutant eye discs than in control discs while no difference is
detected in dE2F2 protein level (Figure 2B). To determine whether
TSC1 regulates the level of de2f1 RNA, we performed real-time
quantitative PCR (RTq-PCR). RNA was isolated from eye discs of
the same genotypes used for immunoblot. We designed de2f1
specific primers that span an intron and amplified portions of two
exons (second and third exons or fourth and fifth exons) to
distinguish the PCR products from cDNA and genomic DNA.
charybdis (chrb), a previously reported TSC1 regulated gene is used as
a positive control [33]. Similar to the published result, we observed
that the level of chrb RNA is increased by 11-fold in tsc1 mutant eye
discs (Figure 2C). However, we could not detect any significant
changes in de2f1 RNA level in tsc1 mutant eye discs (Figure 2C).
Therefore, we concluded that TSC1 regulates dE2F1 expression
post- transcriptionally.
Figure 2. Tsc1 regulates dE2F1 protein expression post-transcriptionally. (A) tsc1
R453X mutant clones are generated in the eye disc as
described previously and immunostained with anti-dE2F1 or anti-dE2F2 antibodies. Images of higher magnification for the indicated areas (dotted
line) are presented in the rightmost panel. The orange line indicates the clonal boundary. Note that the intensity of dE2F1 staining is stronger in tsc1
mutant clones, whereas dE2F2 staining is unaltered. (B) The protein level of dE2F1 and dE2F2 in tsc1 mutant eye discs is determined by immunoblot.
Eye-antenna imaginal discs that are mostly comprised of tsc1 mutant cells are used. b-tubulin is used as a loading control. (C) Quantitative real-time
PCR is used to compare the level of de2f1 RNA in the control (yw) and tsc1 mutant eye discs. The average fold difference of three independent
triplicated experiments is presented. Primers for de2f1 were designed to span an intron, covering either the second and third exons, E1 (2–3) or the
fifth and the sixth exons E1 (5–6). charybdis (chrb), whose expression is known to be upregulated by tsc1 mutations, is used as a positive control. The
error bars indicate standard deviation of the three independent experiments, 61.40 for Chrb, 60.23 for E1 (2–3), and 60.10 for E1 (5–6).
doi:10.1371/journal.pgen.1001071.g002
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mutant cells
Next, we examined whether the transcription of a dE2F1
target gene is activated in tsc1 mutant cells. To address this
question, we used a reporter construct, PCNA-GFP,w h o s eG F P
expression is under the control of the PCNA promoter, a well-
established dE2F1 target gene. As shown in Figure 3, GFP
expression is increased in tsc1 mutant cells in the posterior
portion of the eye disc, suggesting that, at least in this region, the
increase of dE2F1 protein is sufficient to activate the transcrip-
tion of a target gene. Importantly, the abnormal BrdU positive
cells observed in the same region of tsc1 mutant clones are
scarcely present (Figure 1A), indicating that the increase in
dE2F1-reporter activity is not an indirect consequence of ectopic
S-phase cells. We also sought to determine if tsc1 mutations could
further activate dE2F1 target gene expression in rbf1 mutant
cells. Our attempt to compare dE2F1 target gene expression
between rbf1 single and rbf1 tsc1 double mutant eye discs by
RTq-PCR did not provide any conclusive results (data not
shown). This was somewhat expected since a substantial number
of rbf1 tsc1 double mutant cells, presumably cells with
hyperactive dE2F1, undergo cell death (Figure 1B and Figure
S2A). Therefore, we decided to perform an in situ hybridization
experiment, hoping to detect specific changes in a subset of
surviving rbf1 tsc1 double mutant cells. Expression patterns of
dE2F1 target genes (rnrS, Cyclin E,a n dPCNA) were determined
using antisense RNA probes. In wild type eye discs, the
expression pattern of these target genes resembles that of BrdU
staining since their transcription is activated during the G1/S
phase transition (Figure 3B left panel). In rbf1 mutant eye discs,
dE2F1 target genes are strongly expressed at the MF where
dE2F1 protein expression is normally high (Figure 3B middle
panel). It is probable that, in rbf1 mutant eye discs, dE2F1 target
gene expression is mainly controlled by dE2F1 protein level since
cell cycle-dependent regulation by RBF1 is absent. Interestingly,
in rbf1 tsc1 double mutant eye discs, dE2F1 target genes are
strongly expressed both at the MF and in the anterior region of
t h ee y ed i s c( F i g u r e3 Br i g h tp a n e l ) .W er e a s o n e dt h a t ,s i n c erbf1
mutant cells at the MF already express a high level of dE2F1
protein (previously shown in [29]), there is only a small margin
for dE2F1 target gene expression to be further activated by tsc1
mutations. However, in the anterior region of the eye disc where
the dE2F1 protein expression is normally kept low [29], tsc1
mutations can have a greater effect on dE2F1 activity and target
gene expression. As a consequence, dE2F1 target genes are
strongly expressed both at the MF and in the anterior region of
rbf1 tsc1 double mutant eye discs, reaching the threshold of
expression before undergoing cell death. Supporting this idea,
ectopic cell death in rbf1 tsc1 double mutant eye discs is mainly
observed at the MF and in the anterior region of the eye disc
(Figure S2A). Interestingly, we could not detect much increase in
dE2F1 target gene expression in the posterior region of rbf1 tsc1
double mutant eye discs, somewhat contradicting the result
obtained by the PCNA-GFP reporter construct (Figure 3A). One
explanation is that the in situ hybridization experiment is not as
sensitive and quantitative as the PCNA-GFP reporter construct.
We also found that the residual RBF1 proteins in the
hypomorpic rbf1
120a allele are mostly expressed in the posterior
region of the MF, explaining why cells in this region do not show
much an increase in dE2F1 target gene expression (Figure S2B).
Nevertheless, these results indicate that tsc1 mutations can
activate dE2F1 target gene expression in the wild type and rbf1
mutant backgrounds.
dE2F1 is required for the ectopic cell death induced by
rbf1 and tsc1 mutations
To determine if the cooperative effect on cell death by rbf1 and
tsc1 mutations is dE2F1- dependent, we generated an allele with an
FRT chromosome carrying both tsc1 and de2f1 mutations. For this
allele, we used the tsc1
f01910 allele that contains a piggyBac
transposable element inserted in the intron 6 of the tsc1 locus.
Generating tsc1
f01910 clones in rbf1
120a eye discs produces a similar
increase in the level of ectopic cell death observed in Figure 1
(Figure 4A). When tsc1
f01910 and de2f1
729 double mutant clones are
generated in rbf1
120a eye discs, we noticed that the sizes of tsc1
de2f1 double mutant clones are much smaller than that of tsc1
single mutant clones (compare Figure 4A and 4B). The sizes of tsc1
de2f1 double mutant clones in the wild type background are also
small (data not shown), indicating that the loss of de2f1 severely
compromises proliferation of tsc1 mutant cells. Occasionally, we
were able to obtain rbf1
120a mutant eye discs with substantial sizes
of the tsc1 de2f1 double mutant clones. We performed C3 staining
to measure the level of cell death in rbf1, tsc1, and de2f1 triple
mutant cells in these eye discs. Interestingly, the prevailing cell
death phenotype observed in rbf1 tsc1 double mutant cells at the
MF is no longer present in rbf1 de2f tsc1 triple mutant cells
(Figure 4B). This result demonstrates that the increased level of
ectopic cell death observed in rbf1 tsc1 double mutant cells is
dE2F1-dependent.
Rheb regulates dE2F1 expression and dE2F1-dependent
cell death
Next, we asked if the known downstream regulators of TSC1
could regulate dE2F1 expression. We first determined the effect of
rheb loss-of-function mutations on dE2F1 expression by generating
mitotic mutant clones of rheb in the eye disc. Rheb is a Ras
superfamily GTPase whose activity is negatively regulated by
TSC1. As shown in Figure 5A, dE2F1 protein level is reduced,
though not absent, in rheb mutant cells. This is best observed at the
MF where dE2F1 expression is normally high [34]. We then asked
if Rheb is required for the increased dE2F1 expression in tsc1
mutant cells. dE2F1 protein level is also reduced in tsc1 rheb double
mutant cells (Figure 5A), indicating that Rheb is an important
downstream regulator of TSC1 controlling dE2F1 expression. We
concluded that, although not essential, Rheb regulates dE2F1
expression during eye development, and is clearly required for
dE2F1 upregulation in tsc1 mutant cells. Since Rheb controls
dE2F1 expression, we next tested if Rheb is also required for
dE2F1-dependent cell death. To test this, we generated rheb
mutant clones in the rbf1
120a mutant eye disc where deregulated
dE2F1 produces a stripe of apoptotic cells at the anterior region of
the MF (Figure 1A and [29,35]). As shown in Figure 5B, this stripe
of cell death is interrupted by rheb mutant clones. Moreover, the
ectopic cell death observed in rbf1 tsc1 double mutant cells is
completely suppressed by rheb mutations. These results indicate
that Rheb is an important regulator of dE2F1-dependent cell
death as well as dE2F1 expression.
Tor, but neither S6k nor 4E-BP, is required for dE2F1
expression during Drosophila eye development
Rheb activates the Tor serine/threonine kinase, which through
phosphorylation, can either inhibit 4EBP or activate S6k. We
examined whether these proteins downstream of Rheb also
participate in dE2F1 regulation. To address this question, Tor,
s6k, and 4ebp mutant clones were generated in the eye disc. Similar
to what is observed in rheb mutant clones, dE2F1 expression is
reduced, but not absent, in Tor mutant clones, indicating that Tor
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PLoS Genetics | www.plosgenetics.org 5 August 2010 | Volume 6 | Issue 8 | e1001071Figure 3. Transcription of dE2F1 target genes is activated in tsc1 mutant cells. (A) Mitotic clones of tsc1
R453X are generated in the eye disc of
PCNA-GFP transgenic flies. PCNA- GFP is a reporter construct where GFP (green) is expressed under the control of the PCNA promoter, a known dE2F1
target. Wild type clones are marked by the presence of b- galactosidase for this experiment (blue). Note that GFP expression is increased in tsc1
homozygous mutant clones at the posterior of the MF. Images of higher magnification of the mitotic clones are also shown (lower panel). (B) In situ
hybridization assay is used to compare expression patterns of three dE2F1 target genes, rnrS, CycE, and PCNA. rbf1 tsc1 double mutant eye discs are
generated as described previously. Since rbf1 tsc1 double mutant eye discs are generated by mitotic recombination using a recessive cell lethal
mutation, the control and rbf1 eye discs are generated by inducing mitotic recombination between the wild type FRT chromosome against the same
recessive cell lethal mutation (See Materials and Methods). Note the expression of rnrS, CycE, and PCNA in rbf1
120a eye discs is highest at the MF. In
contrast, strong expression of rnrS, CycE, and PCNA is observed both at the MF and in the anterior region of the rbf1 tsc1 double mutant eye disc.
doi:10.1371/journal.pgen.1001071.g003
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ment (Figure 6A). Importantly, dE2F2 expression is unchanged in
Tor mutant clones (data not shown). Based on this observation, we
had hypothesized that dE2F1 expression levels would decrease in
s6k mutant clones and/or increase in 4ebp mutant clones.
Surprisingly, dE2F1 expression is unchanged in either 4ebp or
s6k mutant clones (Figure 6B). These results suggest that Tor is
required for proper dE2F1 expression during eye development
while 4EBP and S6k are dispensable.
S6k is required for the effect of TSC inactivation on dE2F1
expression and dE2F1- dependent cell death
The fact that the loss of neither 4ebp nor s6k has an effect on
dE2F1 expression might indicate a functional redundancy between
the two genes. Alternatively, an unknown factor downstream of
Tor might regulate dE2F1 expression during development.
Nevertheless, we assessed whether S6k is required for the increase
of dE2F1 expression observed when TSC1 is inactivated. We
aimed to generate mitotic clones that are double mutants for tsc1
and s6k. However, because tsc1 and s6k are on the opposite arms of
the third chromosome, we used a mutant allele of tsc2 (or gig in
Drosophila), which is on the same chromosomal arm as s6k. TSC1
and TSC2 function together as a heterodimer, and mutations of
tsc1 or tsc2 yield very similar phenotypes [36–38]. As expected,
dE2F1 expression is elevated in gig mutant clones (Figure 7A).
Furthermore, similar to what was observed in tsc1 mutant clones in
the rbf1
120a mutant background, the level of ectopic cell death was
increased in gig mutant clones generated in rbf1
120a mutant eye
discs (Figure 7B). Surprisingly, the effects of gig mutations on
dE2F1 expression and ectopic cell death are completely suppressed
by s6k loss-of-function mutations. We observed that the level of
dE2F1 expression in s6k gig double mutant clones is unchanged
compared to the control (Figure 7A), and the ectopic cell death
observed in rbf1 gig double mutant cells is completely absent in rbf1
gig s6k triple mutant cells (Figure 7B). Moreover, we observed that
the basal level of dE2F1-dependent cell death normally present in
the rbf1
120a mutant eye disc (the stripe of cell death, Figure 1B) is
also suppressed (Figure 7B). These results indicate that s6k is
required for both the elevation of dE2F1 expression upon TSC
inactivation and the increased level of cell death in rbf1 gig double
mutant cells. In summary, our genetic studies led us to conclude
that TSC1 and TSC2 regulate dE2F1 expression and dE2F1-
dependent cell death via the canonical Rheb/Tor/S6k pathway
during Drosophila eye development.
Discussion
The loss of Rb leads to hyperactivation of E2F family proteins,
which is a crucial event during tumorigenesis. Here, we
demonstrate that the Drosophila ortholog of TSC1 tumor
suppressor cooperates with RBF1 to regulate dE2F1 activity
during development. TSC1 post- transcriptionally regulates
dE2F1 expression, and the loss of tsc1 cooperates with rbf1
mutations to promote unscheduled S-phase entry and cell death.
This effect of tsc1 mutations on dE2F1 expression requires the
components of canonical TSC/Rheb/Tor pathway that are major
regulators of cellular growth. Our study provides evidence to
suggest that dE2F1 is an important protein that couples growth
signals to cell cycle progression.
Recent studies have identified that pro-proliferative and pro-
apoptotic activities of dE2F1 are engaged by various Drosophila
Figure 4. dE2F1 is required for the ectopic cell death induced by tsc1 mutations in the rbf1
120a eye discs. Mitotic clones of tsc1
f01910
single (A) or tsc1
f01910 and de2f1
729 double mutants (B) were generated in the rbf1
120a mutant background. Wild type cells were marked with GFP
(green). Apoptotic cells are visualized by immunostaining with C3. Note that the ectopic cell death induced by tsc1 mutations in rbf1 mutant eye discs
is completely suppressed by de2df1 mutations.
doi:10.1371/journal.pgen.1001071.g004
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findings add tsc1/2 tumor suppressor genes to this list. Previously,
dE2F1 or Cyclin E overexpression is shown to bypass starvation
induced G1 arrest at least in endoreduplicating tissues [39].
Moreover, similar to dE2F1, expression of Cyclin E is elevated in
tsc1 mutant cells in eye imaginal discs. [36–38]. Perhaps,
restricting the expression of cell cycle regulators, such as dE2F1
and Cycline E, is a part of the molecular mechanisms by which
nutrient deprivation induces G1 arrest. Interestingly, overexpres-
sion of dE2F1 or Cycline E does not overcome starvation-induced
G1 arrest in larval neuroblasts, indicating that, in mitotic cells,
neither dE2F1 nor Cycline E is the limiting factor [39]. Consistent
with this observation, we could not observe any appreciable
increase in the size of rheb or Tor mutant clones in rbf1 mutant
Figure 5. Rheb promotes dE2F1 expression during eye development and dE2F1- dependent cell death in rbf1 mutant eye discs. (A)
Mitotic clones of rheb
2D1 or double- mutant clones of rheb
2D1 and tsc1
R453X are generated in the eye discs and immunostained with an anti-dE2F1
antibody (white). Images of higher magnification with outlined clonal boundaries (orange) is also shown. Note the reduced dE2F1 staining in rheb
mutant clones. (B) rheb
2D1 or double-mutant clones of rheb
2D1 and tsc1
R453X are generated in rbf1
120a mutant eye discs and immunostained with C3 to
visualize apoptotic cells (white). Note the discontinued stripe of cell death in rheb mutant clones.
doi:10.1371/journal.pgen.1001071.g005
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proliferative defect observed in rheb or Tor mutant cells in imaginal
discs.
Interestingly, despite the elevated level of dE2F1 and Cyclin
E, tsc1 mutant clones have relatively normal patterns of BrdU
staining at the MF and a limited amount of ectopic cell death.
We believe that the activity of dE2F1 in tsc1 mutant cells is
normally restricted by the presence of RBF1. The fact that the
increase in ectopic S-phase entry and apoptosis by tsc1 mutations
can be only observed in the rbf1 mutant background supports
this idea. We propose that the TSC/Rheb/Tor pathway during
development modulates the amount of dE2F1 needed for cellular
division in proportion to the cell size. Supporting this idea,
previous studies have demonstrated that tsc1 or tsc2 mutant cells
spend less time in G1, a phenotype commonly observed in cells
with elevated dE2F1 activity [36–38,40]. It is conceivable that
the elevated level of dE2F1 proteins in tsc1 or tsc2 mutant cells
allows them to go through G1 to S-phase transition faster where
RBF1 is normally inactivated by Cyclin Dependent Kinases
(CDKs).
Despite being the only ‘‘activator E2F’’ in Drosophila, it is still
unclear how dE2F1 expression is regulated during development. A
recent study reported that Cul4(Cdt2) E3 ubiquitin ligase mediates
destruction of dE2F1 in S-phase, a mechanism that regulates
dE2F1 expression in a cell cycle dependent manner [41]. Our
findings here suggest that the expression of dE2F1 is also regulated
by a growth-controlling network. However, at this point, we do
not know the exact molecular mechanism by which dE2F1 protein
level is post- transcriptionally controlled by the TSC/Rheb/Tor
pathway. The finding that S6k is involved in this process supports
the idea of translational control since S6k directly phosphorylates
and regulates proteins involved in translation, such as RpS6,
eIF4B, and eEF2K to list a few (reviewed in [42]). However, it is
also equally possible that the TSC/Rheb/Tor pathway controls
dE2F1 protein stability. In S2 cells, neither tsc1 RNAi nor
Rapamycin (Tor inhibitor) treatment in S2 cells had the same effect
on dE2F1 expression observed in imaginal discs (Figure S3). It is
probable that S2 cells lack factors necessary for dE2F1 regulation
that are present in vivo. Nevertheless, it is important to note that
this effect on dE2F1 expression is specific since dE2F2 expression
is unchanged in tsc1, rheb or Tor mutant cells (Figure 2A and data
not shown). Curiously, the requirement of S6k to regulate dE2F1 is
limited to the context in which TSC is inactivated. The loss of s6k
in the wild type background has no effect on dE2F1 expression
while rheb or Tor mutations reduce the level of dE2F1 proteins in
the eye disc (Figure 5A and Figure 6). In mammals, it has been
demonstrated that the translation of specific mRNA can be mTor-
dependent but not S6k- dependent [43]. The molecular
mechanism in which S6k promotes dE2F1 expression only when
TSC is inactivated is presently unclear and warrants further
investigation.
Another interesting finding from our study is that s6k mutations
suppress the dE2F1-dependent cell death normally present in rbf1
mutant eye discs (Figure 7). s6k mutations alone did not alter the
dE2F1 expression level at least in the wild type background.
Although it is not formally tested, this raises a possibility that the
Figure 6. Tor is required for dE2F1 expression during eye development, but neither s6k or 4ebp mutations affect dE2F1 expression.
(A) Mitotic clones of Tor
2L19 are generated in the eye discs and immunostained with an anti-dE2F1 antibody (white). Images of higher magnification
with outlined clonal boundaries (orange) are also shown. dE2F1 staining is clearly reduced in the tor mutant clones. (B) s6k
l-1 or 4ebp
null mutant
clones are generated as described previously. In contrast to Tor mutant clones, dE2F1 expression is unchanged in the mutant clones of either
genotype.
doi:10.1371/journal.pgen.1001071.g006
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without altering dE2F1 expression. Interestingly, the crosstalk
between the InR/Tor and the EGFR signaling pathways during
Drosophila eye development has been recently established [44].
InR/Tor signaling regulates the timing of neuronal differentia-
tion in the eye disc by modulating EGFR activity. Since the
EGFR pathway is an important determinant of dE2F1-dependent
cell death [29], S6k might promote dE2F1-dependent cell death
by modulating the EGFR pathway. We speculate that the
cooperative effect between tsc1 and rbf1 mutations is the
Figure 7. S6K is required for the effect of TSC inactivation on dE2F1 expression and dE2F1-dependent cell death in rbf1
120a eye
discs. (A) Mitotic clones of gig
192 single or s6k
l-1 and gig
192 double mutant clones are generated in the eye discs. The intensity of the GFP indicates
that GFP expressing clones are composed of two genotypes, wild type and heterozygous mutations (eg. gig+/+ or gig+/2). An anti-dE2F1 antibody
(white) is used to determine the expression pattern of dE2F1. Images of higher magnification with outlined clonal boundaries (orange) are also
presented. Note that dE2F1 expression is unchanged in s6k gig double mutant clones contrary to gig single mutant clones where dE2F1 level is clearly
elevated. (B) gig
192 single or s6k
l-1 and gig
192 double mutant clones are generated in rbf1
120a mutant eye discs and stained with C3 to visualize
apoptotic cells. The increased level of apoptosis by gig mutations is suppressed by s6k mutations.
doi:10.1371/journal.pgen.1001071.g007
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dE2F1 expression.
In cancer cells, it is generally thought that the loss of Rb
function is the most common mechanism of deregulating E2F
activity. However, in some types of cancers, amplification of E2F
genes or overexpression of E2F family proteins have been
observed (reviewed in [23]). Moreover, in a subtype of human
retinoblastoma where Rb is already deficient, E2f-3 proteins are
also overexpressed [45]. These observations suggest that E2F
family genes themselves can be directly targeted and deregulated
during tumorigenesis. It will be interesting to investigate if TSC1/
2 or other tumor suppressors and oncogenes regulate the
expression of E2F family proteins to promote tumorigenesis.
Materials and Methods
Fly stocks
All crosses have been performed at 25uC. The rbf1 mutant
allele, rbf1
120a, and de2f1 allele, de2f1
729, are described previously
[15,16]. The tsc1 alleles used in this study are tsc1
R453X, a gift from
Dr. Hariharan [38], and tsc1
f01910 (Exelixis collection, Harvard
Medical School). The mutant alleles of the TSC/Rheb/Tor
pathway used in this study are as follows: Tor
2L19 FRT40A and
4ebp
null are gifts from P. Lasko [46,47]. s6k
l-1 FRT80B is a gift from
D.J. Pan [48]. The gig
56 FRT80B, FRT82B rheb
2D1, and s6k
l-1
gig
192FRT80B alleles were kindly provided by J.M. Bateman [44].
The 4ebp
null FRT40A, FRT82B de2f1
729 tsc1
f01910, and FRT82B
rheb
2D1 tsc1
R453X alleles were generated by meiotic recombination.
For the double mutant alleles, presence of both mutations is
verified by genetic complementation tests using multiple mutant
alleles. For example, presence of both s6k and gig mutations in
s6k
l-1gig
192 FRT80B alleles were verified by crossing the alleles to
gig
52, gig
192, s6k
l-1 and s6k
p{PZ}07084 alleles individually.
Clonal analysis
Flippase (FLP) was expressed from the eyeless promoter to generate
mitotic clones in the eye. To examine clones in rbf1 mutant animals,
the X chromosome carrying rbf1
120a and an ey-FLP transgene was
used. Followings are the full genotypes of larvae analysed.
Mutant clones in the wild-type background
y w eyFlp/+ or Y; FRT82B GFP
ubi/FRT82B tsc1
R453X
y w eyFlp/+ or Y; FRT82B GFP
ubi/FRT82B rheb
2D1
y w eyFlp/+ or Y; FRT82B GFP
ubi/FRT82B rheb
2D1 tsc1
R453X
y w eyFlp/+ or Y; GFP
ubi FRT40A/Tor
2L19 FRT40A
y w eyFlp/+ or Y; GFP
ubi FRT80B/s6k
l-1 FRT80B
y w eyFlp/+ or Y; GFP
ubi FRT40A/4ebp
null FRT40A
y w eyFlp/+ or Y; GFP
ubi FRT80B/gig
56 FRT80B
y w eyFlp/+ or Y; GFP
ubi FRT80B/s6k
l-1 gig
192 FRT80B
Mutant clones in the rbf1
120a background
w rbf1
120a eyFlp/Y; FRT82B GFP
ubi/FRT82B tsc1
R453X
w rbf1
120a eyFlp/Y; FRT82B GFP
ubi/FRT82B tsc1
f01910
w rbf1
120a eyFlp/Y; FRT82B GFP
ubi/FRT82B de2f1
729 tsc1
f01910
w rbf1
120a eyFlp/Y; FRT82B GFP
ubi/FRT82B rheb
2D1
w rbf1
120a eyFlp/Y; FRT82B GFP
ubi/FRT82B rheb
2D1 tsc1
R453X
w rbf1
120a eyFlp/Y; GFP
ubi FRT80B/gig
56 FRT80B
w rbf1
120a eyFlp/Y; GFP
ubi FRT80B/s6k
l-1 gig
192 FRT80B
Immunoblot, real-time quantitative PCR, and in situ
hybridization
y w eyFlp/Y; FRT82B [W+] l(3)cl-R3/FRT82B (controls)
y w eyFlp/Y; FRT82B [W+] l(3)cl-R3/FRT82B tsc1
R453X
w rbf1
120a eyFlp/Y; [W+] l(3)cl-R3/FRT82B
w rbf1
120a eyFlp/Y; [W+] l(3)cl-R3/FRT82B tsc1
R453X
PCNA-GFP in tsc1 mutant clones
y w eyFlp/PCNA-GFP; FRT82B LacZ
arm/FRT82B tsc1
R453X
Immunostaining and microscopy
The antibodies used in this study are: anti-dE2F1 (1/1000) [29],
anti-dE2F2 (1/1000) [34], anti-RBF1 (1/100) from Dyson Lab,
anti-C3 (1/200, Cell Signaling), anti-GFP-FITC (1/200, abcam),
anti-b-galactosidase (Developmental Studies Hybridoma Banks
[DSHB]), and anti- ELAV (DSHB). For immunostaining, third-
instar eye discs were fixed in 4% formaldehyde for 20 minutes at
room temperature (eye discs immunostained for anti-dE2F1 were
fixed at 4uC for 30 minutes) and washed twice with 0.3% PBST
(0.3% Triton X-100 in PBS) and once with 0.1% PBST (0.1%
Triton X-100 in PBS). Fixed eye discs were incubated in primary
antibody with 0.1% PBST and 5% normal goat serum (NGS) at
room temperature for 3 hours. After four washes with 0.1%
PBST, eye discs were incubated in secondary antibody with 0.3%
PBST and 5% NGS at room temperature for 2 hours.
Immunostained eye discs were then washed five times with 0.1%
PBST at room temperature and mounted for confocal microscopy
imaging (Zeiss LSM).
In situ hybridization
For in situ hybridization experiments, eye-antennal discs were
prepared as described previously [26]. Anti-sense RNA probes
were generated using cDNA clones LD41588, LD17578, and
LD45889 for rnrS, CycE, and PCNA respectively. After hybridiza-
tion, Alkaline Phosphatase conjugated anti-DIG antibodies were
used to detect DIG labeled anti- sense RNA probes. For each
target genes, more than 20 eye antennal discs were analyzed and
the representative images were chosen to be presented.
Immunoblotting
40 eye discs of tsc1 mutant and control animals were dissected
and used for Western blot as previously described [29].
Real-Time Reverse Transcriptase PCR
The average of three independent experiments of triplicate-
PCR reaction is presented. Total RNA was isolated from 40 eye-
antenna eye discs with RNeasy Mini kit (QIAGEN) according to
manufacturer’s protocol, and reverse transcribed using DyNAmo
cDNA Synthesis Kit (Finnzymes) according to manufacturer’s
instructions. Quantitative PCR reactions were performed with
DyNAmo Flash SYBR Green qPCR Kit (Finnzymes). Quantifi-
cation was determined by comparative threshold cycle method
(CT) on Bio-Rad CFX Manager software. Both rp49 and b-tubulin
were used as normalization controls in a single experiment. All
primers were designed with Primer3 (Whitehead Institute fozr
Biomedical Research primer3 shareware [http://frodo.wi.mit.
edu/primer3/]). Primer pairs used are:
chrb1F (AACTGCAGGCTCAGCTACG)
chrb1R (CGCTCTCGAACTCAATGAAG)
de2f12-3F (CAGCACCACCACCAAAATC)
de2f12-3R (ACTGCTAGCCGTATGCTTCTG)
de2f15-6F (TACAGCCATGACCGCAAC)
de2f15-6R (GTTCAGCGCATACGGATAGTC)
tubulin-F (ACATCCCGCCCCGTGGTC)
tubulin-R (AGAAAGCCTTGCGCCTGAACATAG)
Rp49-F (TACAGGCCCAAGATCGTGAAG)
Rp49-R (GACGCACTCTGTTGTCGATACC)
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Figure S1 Tsc1 regulates dE2F1 protein level both in prolifer-
ating and differentiating cells in imaginal discs. (A) tsc1
R453X
mutant clones are generated in the eye- antenna disc as previously
described and immunostained with an anti-dE2F1 antibody.
Images at two different focal planes of a single eye disc are
shown. The upper panel shows increased expression of dE2F1
proteins in tsc1 mutant clones at the anterior region of the eye disc.
The lower panel shows increased dE2F1 expression in tsc1 mutant
clone at the posterior region of the eye disc. The magnified views
of indicated area are also presented. (B) An antenna disc that
contains tsc1
R453X mutant clones is shown. As in eye imaginal discs,
dE2F1 expression is increased in tsc1 mutant clones. (C) tsc1
R453X
mutant clones are generated in the wing disc using heat shock
driven Flippase. Presumptive notum area of the wing disc is
shown. Note the increased level of dE2F1 proteins in tsc1 mutant
clones.
Found at: doi:10.1371/journal.pgen.1001071.s001 (3.18 MB TIF)
Figure S2 The pattern of ectopic cell death in eye imaginal discs
that are mostly composed of rbf1 tsc1 double mutant cells. (A) The
patterns of cell death between an rbf1
120a eye disc and two eye
discs carrying both rbf1
120a and tsc1
R453X mutations are shown (see
Materials and Methods). Apoptotic cells are visualized by the C3
antibody. A dramatic increase in C3 staining is observed at the MF
and in the anterior region of the eye discs carrying both rbf1 and
tsc1 mutations. (B) rbf1
120a mutant clones, marked by absence of
GFP, are generated in the eye discs. Note the weak but visible
RBF1 staining in rbf1
120a mutant clones in the region posterior to
the MF (yellow asterisk).
Found at: doi:10.1371/journal.pgen.1001071.s002 (1.38 MB TIF)
Figure S3 Inactivation of tsc1 nor Tor affects dE2F1 protein level
in S2 Drosophila tissue culture cells. (A) S2 cells are treated with
either white or tsc1 double strand RNA for 4 days and dE2F1
protein levels are measured by immunoblot. The antibody that
recognizes the phospho-specific form of S6k (Cell Signaling, Cat#.
9206) is used to monitor the effect of tsc1 depletion and anti-b-
tubulin antibodies are used for loading control. Three independent
experimental results are presented. (B) S2 cells are treated with
DMSO or DMSO containing Rapamycin (the final concentration
of 20 nM). After 16 hours of treatment, dE2F1 protein levels are
measured by immunoblot. A phospho-specific S6k antibody is
used to monitor the effect of Rapamycin treatment. For each lane,
an equal amount of protein extract is loaded 28. (C) S2 cells are
treated as described in (B). However, the amount of protein extract
loaded in each lane is normalized by cell number and not by
protein concentration. Note that S2 cells do not recapitulate the
effect observed in imaginal discs.
Found at: doi:10.1371/journal.pgen.1001071.s003 (0.22 MB TIF)
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